Midwife Licensure Exam Normal Pregnancy, Labor & Postpartum — Prenatal Care & Maternal NutritionStudy Notes

The primary goals of prenatal care are to maintain maternal and fetal health, screen for risk factors early, provide the woman with knowledge and confidence for safe birth, and prepare her for breastfeeding and newborn care. Quality prenatal care reduces maternal and perinatal mortality and morbidity through early detection and management of complications such as hypertension, diabetes, infection, and abnormal fetal growth. In the Philippines, the DOH recommends a minimum of four antenatal care (ANC) visits during pregnancy. However, the World Health Organization's 2016 revised guidance recommends at least eight contacts with skilled health workers for improved maternal and newborn outcomes. These visits follow a progressive schedule based on gestational age: • **Every 4 weeks until 28 weeks of gestation** — This early phase focuses on dating, baseline health status, and risk assessment. • **Every 2 weeks from 28 to 36 weeks** — This phase emphasizes growth monitoring and screening for complications such as gestational diabetes and pre-eclampsia. • **Every week from 36 weeks until delivery** — This final phase focuses on fetal positioning, birth readiness, and danger-sign assessment. High-risk pregnancies (such as those with maternal hypertension, diabetes mellitus, multiple gestation, history of adverse pregnancy outcomes, or teenage pregnancy) require more frequent visits and closer monitoring. The nurse's role is to ensure adherence to the schedule, assess barriers to attendance, and create a supportive environment that encourages continued engagement. **The First (Booking) Visit** is the most comprehensive and typically occurs in the first trimester. This foundational visit includes: • **Detailed health history**: Complete menstrual history to establish last menstrual period (LMP), obstetric history using the GTPAL notation (Gravidity, Term births, Preterm births, Abortions, Living children), current obstetric complaints, past medical and surgical history, family history, social and occupational history, and risk-factor screening. • **Estimation of expected date of delivery (EDD)** using Naegele's rule: LMP + 7 days, then add 9 months (or subtract 3 months). For example, if LMP is January 15, the EDD is approximately October 22. • **Complete physical examination**: General appearance, vital signs, weight (baseline for monitoring gain), and examination for signs of illness or abnormality. • **Pelvic examination**: Assessment of external genitalia, vaginal canal (noting discharge, lesions, or infection), cervix (noting position, consistency, dilation, and effacement), uterus (noting size and tenderness), adnexal structures (noting masses or tenderness), and pelvic outlet adequacy. Pelvic adequacy is crucial because fetopelvic disproportion is a leading indication for cesarean delivery in resource-limited settings. • **Baseline laboratory investigations** (critical for risk stratification and management): - Blood type and Rh factor (essential because Rh-negative women require anti-D immunoglobulin to prevent isoimmunization) - Complete blood count (CBC) and hemoglobin level (baseline for screening anemia) - Fasting blood glucose or random blood glucose (baseline for gestational diabetes screening) - Urinalysis (protein, glucose, leukocytes, nitrites to screen for asymptomatic bacteriuria and proteinuria) - Syphilis screening (VDRL or RPR) to allow early treatment and prevent congenital syphilis - HIV antibody testing (with informed consent and counseling) - Hepatitis B surface antigen (HBsAg) to identify carrier status and prevent vertical transmission **Rh-negative women** are a special population requiring close attention. Early identification allows for timely administration of anti-D immunoglobulin (RhoGAM) at approximately 28 weeks of gestation (~500 IU or 100 mcg intramuscularly) and within 72 hours after delivery if the infant is confirmed Rh-positive. This prevents Rh alloimmunization and hemolytic disease of the newborn in future pregnancies. **Every-Visit Assessment** (the ongoing screen conducted at all subsequent visits) includes: • **Maternal weight and blood pressure**: Weight is plotted at each visit to track total gestational weight gain (expected range: 11.5–16 kg for normal-weight women). A sudden increase in weight, especially with edema and hypertension, may signal pre-eclampsia. Blood pressure is compared to baseline and early pregnancy values; a rise of ≥30 mmHg systolic or ≥15 mmHg diastolic (or absolute BP ≥140/90) warrants investigation. • **Urine dipstick**: Screened for proteinuria (may indicate pre-eclampsia or underlying renal disease) and glucosuria (may indicate gestational diabetes or glycosuria of pregnancy). • **Fundal height measurement**: After 20 weeks, fundal height in centimeters should roughly approximate gestational age in weeks (±2 cm). For example, at 24 weeks, fundal height should be approximately 24 cm measured from the symphysis pubis to the top of the uterine fundus. Deviation from expected growth may indicate multiple gestation, polyhydramnios, fetal growth restriction, or incorrect dating. • **Fetal heart rate (FHR) auscultation**: Normally 110–160 beats per minute. By 12 weeks, fetal heart may be audible with a handheld doppler; by 20 weeks, it is reliably heard with a fetoscope. Absence of a detectable FHR when expected is a danger sign warranting immediate ultrasound evaluation. • **Fetal movement assessment**: After quickening (typically 16–20 weeks), the woman is taught to monitor fetal movements using a "kick count" method—counting distinct fetal movements daily, aiming for at least 10 movements in up to 2 hours. Fewer than 6 movements in 2 hours may indicate fetal distress and requires evaluation. • **Leopold's maneuvers** (after 24 weeks): A systematic palpation technique to determine fetal lie (longitudinal, transverse, oblique), presentation (vertex/cephalic, breech, shoulder), position (right/left, anterior/posterior), and engagement. This information guides counseling about delivery options and prepares for labor management. • **Review of danger signs and concerns**: Every visit includes reinforcement of danger-sign recognition and an open-ended question about the woman's physical, emotional, and social wellbeing. **Screening Tests by Trimester and Timing**: • **First trimester (up to 13 weeks)**: Ultrasound for accurate dating (most accurate in the first trimester, ±3–5 days margin of error); nuchal translucency screening for chromosomal abnormalities (if available); blood pressure and urine baseline. • **Second trimester (13–27 weeks)**: Maternal serum screening (alpha-fetoprotein, human chorionic gonadotropin, unconjugated estriol) for Down syndrome and neural tube defects (if available); anatomy ultrasound at 18–22 weeks to assess fetal structure, placental location, amniotic fluid volume, and umbilical cord; oral glucose tolerance test (OGTT) at 24–28 weeks for gestational diabetes screening (fasting glucose ≥126 mg/dL, 1-hour glucose ≥180 mg/dL, 2-hour glucose ≥155 mg/dL, or 3-hour glucose ≥140 mg/dL suggests diagnosis). • **Third trimester (28–40 weeks)**: Repeat CBC and urinalysis; Group B Streptococcus (GBS) screening at 36–37 weeks in settings where available (positive culture indicates need for intrapartum antibiotic prophylaxis to prevent early neonatal sepsis); antenatal fetal monitoring with non-stress testing or biophysical profile if indicated for high-risk pregnancies.

Prevention of maternal and neonatal tetanus is a cornerstone of the Philippine maternal immunisation program. Tetanus immunity is transferred passively from mother to newborn through placental antibodies (IgG), protecting the newborn from neonatal tetanus (a serious condition with high mortality) in the first weeks of life. The DOH provides tetanus-diphtheria (Td) vaccine to pregnant women and women of childbearing age to ensure both maternal protection and passive fetal/neonatal protection. **Immunisation Schedule for a Previously Unimmunised Pregnant Woman**: A woman who has never received tetanus vaccination requires a series of doses spaced at defined intervals. In pregnancy, the goal is to complete at least two doses (Td1 and Td2) so that the newborn receives passive protection (a "Child Protected at Birth" or CPAB status). • **Td1 (First dose)**: Administered as early as possible in pregnancy at the first antenatal contact. This dose initiates the immune response but does not yet confer protection to the mother or fetus. Given IM in the deltoid, 0.5 mL. • **Td2 (Second dose)**: Administered ≥4 weeks after Td1 and ideally ≥2 weeks before the expected date of delivery. This dose is critical because maternal antibodies produced after Td2 are transferred across the placenta, protecting the newborn from neonatal tetanus for approximately 3 years. If the woman does not deliver within 2 weeks after Td2, some guidelines recommend giving the dose earlier (e.g., at 32 weeks) to ensure adequate antibody transfer. Given IM, 0.5 mL. • **Td3 (Third dose)**: Administered ≥6 months after Td2 (can be given in the early postpartum period or after return for postpartum care at 6 weeks). Provides protection for ~5 years. • **Td4 (Fourth dose)**: Administered ≥1 year after Td3. Provides protection for ~10 years. • **Td5 (Fifth dose)**: Administered ≥1 year after Td4. Provides lifelong immunity. **Special Situations**: • **Woman with prior Td vaccination history**: If she has received ≥2 prior Td doses, she typically needs a booster (Td) if her last dose was >5 years ago. This booster is given in pregnancy to boost antibody levels for passive fetal transfer. • **Woman with Td toxoid allergy (rare)**: Diptheria and tetanus immunoglobulins may be considered, though this is uncommon and managed on a case-by-case basis. • **Postpartum and breastfeeding**: Td is safe to give in the immediate postpartum period and does not contraindicate breastfeeding. The vaccine does not enter breast milk in active form. **Clinical Significance**: Neonatal tetanus occurs when a newborn is not passively protected by maternal antibodies and develops tetanus from contamination of the umbilical cord (e.g., from non-sterile cord cutting or care practices). It presents with locked jaw, rigidity, and convulsions and has a high fatality rate in resource-limited settings. By ensuring that at least Td2 is given before or early in pregnancy, the Philippines has dramatically reduced neonatal tetanus mortality. Nurses play a crucial role in ensuring that all pregnant women, even those presenting late in pregnancy, receive at least one dose of Td if they have not been previously vaccinated. **Documentation and Tracking**: All Td doses are documented in the pregnant woman's health record and in her immunisation card (health passport). The nurse verifies prior vaccination history at each visit and plans for any missing doses. Community health workers and midwives at the barangay level also track Td status to ensure no pregnant woman is missed.

Nutritional supplementation during pregnancy is essential for supporting fetal development, maintaining maternal health, preventing common complications, and preparing for lactation. The Philippine DOH recommends a standard supplementation regimen that addresses the most common nutritional deficiencies in the population. **Iron and Folic Acid Supplementation**: The DOH standard regimen is **60 mg elemental iron + 400 micrograms (mcg) folic acid daily throughout pregnancy and continued into the early postpartum period**. This combination addresses two critical needs: • **Iron (60 mg elemental iron daily)** serves multiple functions in pregnancy: - Expands maternal blood volume (which increases ~40–50% by term) and red blood cell mass by ~20%. This physiological expansion is necessary to accommodate increased oxygen delivery to the placenta and fetus and to prepare for blood loss at delivery. - Prevents and treats iron-deficiency anemia, which affects ~25–30% of pregnant women globally and is even more prevalent in the Philippines due to dietary patterns, infections (hookworm, malaria), and rapid population turnover. Anemia in pregnancy is associated with poor fetal growth, prematurity, low birth weight, and increased maternal fatigue and infection risk. - Supports fetal iron stores; the fetus accumulates ~250 mg iron during pregnancy, with most storage occurring in the third trimester. Maternal iron deficiency during this period may result in low infant iron stores and increased risk of early childhood anemia. - Aids postpartum recovery by maintaining hemoglobin levels despite blood loss (~500 mL with vaginal delivery, ~1000 mL with cesarean delivery). • **Folic acid (400 mcg daily)** is crucial for: - **Prevention of neural tube defects (NTDs)**—the most critical function. Neural tube closure occurs between weeks 3 and 4 of gestation, often before a woman realizes she is pregnant. Periconceptional folic acid (400 mcg daily, ideally beginning 1 month before conception) reduces the risk of NTDs by ~70%. This is why the DOH and Philippine health programs emphasize folic acid in all women of childbearing age, not just pregnant women. Women with a prior history of NTD pregnancy should receive high-dose folic acid (4–5 mg daily) starting before conception and continuing through the first trimester. - **Red blood cell (RBC) formation and DNA synthesis**. Pregnancy increases RBC turnover and demand for folate. Folic acid deficiency can contribute to megaloblastic anemia, which further impairs oxygen delivery to the fetus. - **Protein and amino acid metabolism**, supporting overall fetal growth. **Teaching on Iron Intake**: Many pregnant women experience gastrointestinal upset (nausea, constipation, dark stools, abdominal discomfort) when taking iron, leading them to skip doses or stop entirely. The nurse's role includes practical problem-solving: • **Timing and absorption**: Iron is best absorbed on an empty stomach (1 hour before or 2 hours after meals). However, if GI upset is severe, iron can be taken with food (though absorption is reduced by ~20–30%). If food is necessary, advise pairing with vitamin C-rich foods (citrus, guava, tomatoes) to enhance absorption. • **Substances that reduce iron absorption** and should be taken separately from iron (ideally 2 hours apart): - Milk and dairy products (calcium competes for absorption) - Tea and coffee (tannins form complexes with iron) - Antacids and calcium supplements (increase gastric pH, reducing iron solubility) - High-fiber foods (when taken together) • **Substances that enhance iron absorption**: - Vitamin C (ascorbic acid) — include citrus, guava, tomatoes, papaya at or around the iron dose - Meat, poultry, fish (heme iron and animal protein enhance non-heme iron absorption) • **Expected side effects** (often seen as adverse, but actually harmless and expected): - **Dark or black stools** are normal and result from unabsorbed iron oxidation in the colon. This is reassuring, not alarming, and indicates the supplement is present. - **Constipation** is common due to iron's astringent effect. Manage with increased dietary fiber (fruits, vegetables, whole grains), adequate fluid intake (6–8 glasses/day), and regular physical activity (walking). Stool softeners or mild laxatives (e.g., docusate) can be suggested but are not usually necessary. - **Nausea and abdominal discomfort** can be minimized by taking iron with a light snack or splitting the dose (e.g., 30 mg twice daily instead of 60 mg once daily). - **Metallic taste** may be noted and is harmless. • **Storage safety**: Emphasize that iron supplements must be stored out of reach of children. Iron overdose in young children is dangerous and can be fatal, causing GI hemorrhage, shock, and hepatic damage. If accidental ingestion is suspected, emergency medical care should be sought immediately. • **Adherence strategies**: - Partner medication-taking with an existing daily habit (e.g., "Take it with breakfast"). - Use a pill organizer or calendar to track doses. - Involve the family in reminding and supporting the pregnant woman. - If side effects persist despite strategies, discuss with the healthcare provider about timing adjustments or alternative formulations (e.g., iron polysaccharide instead of ferrous sulfate). - Reassure the woman that missing an occasional dose is not catastrophic; consistent adherence over time matters most. **Calcium Supplementation**: The role of calcium in pregnancy has expanded in recent years. Calcium: • **Supports fetal skeletal development**: The fetus accumulates ~25–30 g of calcium during pregnancy, particularly in the third trimester. Calcium is essential for fetal bone mineralization, tooth bud formation, and neuromuscular function. • **May reduce pre-eclampsia risk**: Several large trials (CPEP trial in low-income countries) have shown that calcium supplementation (1000–1200 mg daily) reduces the risk of pre-eclampsia by ~30–35%, particularly in women with low baseline dietary calcium intake. The Philippines has a significant proportion of women with low dietary calcium intake due to limited access to milk and dairy; calcium supplementation is therefore recommended. • **Supports maternal wellbeing**: Adequate calcium intake maintains maternal bone density and prevents pregnancy-related hyperparathyroidism, which would otherwise draw calcium from maternal bones to meet fetal demands. **Dosing**: WHO and DOH recommend **1000–1200 mg elemental calcium daily** for pregnant women, particularly those at risk for pre-eclampsia or with low dietary calcium intake. Calcium is best absorbed in divided doses (500 mg at a time) taken with meals. Dietary sources (small fish eaten with bones like dilis, dairy, dark leafy greens, tofu) are preferred, with supplementation filling gaps. **Iodine**: Iodine is a critical micronutrient for fetal brain development and thyroid function. The Philippines addresses iodine deficiency partly through the **ASIN Law (RA 8172—Iodine Deficiency Disorder Prevention Act)**, which mandates iodized salt in commerce. However, not all households use iodized salt consistently, and pregnant women may benefit from supplementation or additional dietary sources: • **Dietary sources**: Seafood (fish, shrimp), seaweed (if culturally acceptable), eggs, and iodized salt. • **Supplementation**: The WHO and some countries recommend iodine supplementation (150 mcg daily) in regions with iodine deficiency. In the Philippines, this is context-dependent and guided by iodine-status surveys and regional recommendations. **Vitamin A**: Vitamin A is essential for fetal eye development, immune function, and epithelial health. However, **high-dose vitamin A is teratogenic**: • **Safe intake**: The recommended dietary allowance (RDA) for pregnant women is 770 mcg/day (retinol activity equivalent). This should be met through food sources (liver, eggs, fortified milk, orange and dark green vegetables like malunggay). • **Avoid megadoses and retinoid medications**: Vitamin A supplements in doses >10,000 IU/day (3000 mcg/day), particularly in the first trimester, are associated with increased risk of fetal malformations (cleft palate, cardiac defects, CNS and thymic abnormalities). Isotretinoin (a derivative of vitamin A used for severe acne) is an absolute contraindication in pregnancy (Category X). • **Counsel women**: Pregnant women should not take separate vitamin A supplements unless specifically recommended by their healthcare provider for deficiency. Prenatal vitamins formulated for pregnancy contain safe amounts of vitamin A. **Other Micronutrients**: While not universally supplemented, other micronutrients support healthy pregnancy: • **Vitamin D**: Supports calcium absorption and fetal bone development. Dietary sources include fatty fish and egg yolks; sun exposure also stimulates synthesis. Supplementation is recommended in regions with limited sun exposure. • **Vitamin C**: Enhances iron absorption and supports immune function. Dietary sources (citrus, guava, tomatoes, papaya) are abundant in the Philippines. • **Vitamin B12**: Essential for RBC formation and neurological development. Women on restricted diets or with pernicious anemia may need supplementation. • **Vitamin E**: An antioxidant that supports fetal development, though supplementation is not routine unless deficiency is documented.

Good nutrition during pregnancy is fundamental to maternal health, fetal development, birth weight, and lactation readiness. Pregnancy creates increased metabolic demands and nutrient requirements, and the nurse must counsel women on achieving adequate intake within the constraints of cultural preferences, food security, and economic resources. **Recommended Weight Gain**: Total gestational weight gain depends on the woman's pre-pregnancy body mass index (BMI), calculated as weight (kg) ÷ height (m²). The Institute of Medicine (IOM) recommendations, adopted by most maternal health guidelines, are: | Pre-pregnancy BMI | Classification | Recommended Total Gain (kg) | Recommended Total Gain (lbs) | |---|---|---|---| | <18.5 | Underweight | 12.5–18 | 28–40 | | 18.5–24.9 | Normal weight | 11.5–16 | 25–35 | | 25–29.9 | Overweight | 7–11.5 | 15–25 | | ≥30 | Obese | 5–9 | 11–20 | These recommendations are based on evidence that they optimize both fetal outcomes (birth weight, reduced prematurity) and maternal outcomes (reduced postpartum weight retention, reduced hypertension and diabetes complications). **Pattern of Weight Gain Across Trimesters**: • **First trimester** (~0–13 weeks): Minimal weight gain, typically **1–2 kg total** (~0.5 kg/week or less). Most fetal weight gain occurs in the third trimester, not the first; women should not be encouraged to "eat for two" early in pregnancy. Nausea and vomiting (morning sickness) often limit intake in this period; weight loss of 1–2 kg is acceptable and not harmful. • **Second trimester** (~14–27 weeks): Progressive gain of approximately **~0.4–0.5 kg/week** (0.5 lbs/week). For a normal-weight woman aiming for 11.5–16 kg total, this would mean ~6–8 kg gained by the end of the second trimester. • **Third trimester** (~28–40 weeks): Continued gain of approximately **~0.4–0.5 kg/week** for a normal-weight woman, though patterns vary. About **half of all pregnancy weight gain** occurs in the third trimester, reflecting rapid fetal growth (the fetus weighs ~3.5 kg at term), placental growth, amniotic fluid expansion (to ~1 liter), and maternal blood and tissue expansion. **Composition of Weight Gain**: The ~12–16 kg gained by a normal-weight woman is distributed as follows: • Fetus: ~3.5 kg • Placenta: ~0.6 kg • Amniotic fluid: ~0.8–1 kg • Maternal blood (expanded volume): ~1.5–2 kg • Maternal extracellular fluid (edema, especially third trimester): ~1–2 kg • Maternal tissue (breast, uterine, fat stores): ~2–3.5 kg Understanding this composition helps the nurse counsel women that weight gain is mostly necessary physiological expansion, not excess fat. **Red Flags for Abnormal Weight Gain**: • **Excessive rapid gain** (>2 kg/week or >0.5 kg/day) combined with edema, headache, visual changes, or upper abdominal pain suggests pre-eclampsia and requires urgent evaluation. • **Poor weight gain** (<0.5 kg/week in the second and third trimesters) or weight loss (except in the first trimester) may indicate inadequate nutrition, hyperemesis gravidarum, infection, or fetal growth restriction. • **Sudden plateau in gain** after progressive gain may indicate placental insufficiency or fetal growth restriction.

Pregnancy significantly increases nutritional demands. The nurse must counsel pregnant women on meeting these increased needs through balanced, accessible foods that align with Filipino dietary patterns and cultural preferences. **Energy (Caloric) Requirements**: • **First trimester**: No additional energy is needed beyond the non-pregnant requirement (typically ~1800–2000 kcal/day for a sedentary woman; more for active women). The common phrase "eating for two" is misleading in early pregnancy. • **Second trimester**: An additional **~340 kcal/day** is recommended (total ~2140–2340 kcal/day for a typical woman). This is roughly equivalent to an extra apple with peanut butter, a glass of milk with a slice of bread, or a small serving of rice with fish. • **Third trimester**: An additional **~450 kcal/day** is recommended (total ~2250–2450 kcal/day). This reflects the accelerating fetal growth rate. A practical, simplified teaching message often used is **"an extra 300 kcal/day throughout pregnancy"** or **"about 500 extra calories per day in the last trimester."** These are approximations; exact needs vary by maternal activity level, body composition, and individual metabolism. **Protein**: • **Requirement**: Pregnant women require approximately **+25 g/day above non-pregnant needs** (total RDA ~71 g/day for most women, ranging from 60–71 g depending on body weight). Protein supports: - Expansion of maternal blood volume and synthesis of plasma proteins (albumin, immunoglobulins, clotting factors) - Uterine growth and myometrial hypertrophy - Placental development and function - Fetal tissue synthesis (muscle, organ growth, immune and neurological proteins) - Amniotic fluid composition (contains fetal proteins and maternal albumin) • **Protein quality and sources**: Complete proteins (containing all essential amino acids) are preferable. In the Philippines, affordable, locally available sources include: - **Fish and seafood** (tilapia, milkfish, sardines) — excellent source of complete protein, omega-3 fatty acids, and minerals - **Eggs** — complete protein, choline (for fetal brain development), affordable - **Poultry** (chicken, duck) — complete protein, iron - **Dried legumes** (mongo beans, kidney beans, lentils) — plant-based complete protein when combined with grains (e.g., mongo with rice), fiber, iron, folate - **Tofu and soy products** — complete protein, affordable, versatile - **Milk and dairy** — protein, calcium, vitamin B12 (important as cow's milk is a primary dietary B12 source in non-Western diets) • **Counsel on variety**: Encourage mixing animal and plant proteins to ensure adequate intake and diversity of micronutrients. **Carbohydrates**: • **Role**: Carbohydrates provide the primary energy source for fetal development and maternal metabolism. Adequate carbohydrates also "spare" protein, meaning protein can be used for tissue synthesis rather than energy. • **Recommended intake**: ~50–60% of total daily calories (typical recommendation); no specific absolute minimum is defined, but insufficient carbohydrates can lead to ketosis, which may adversely affect fetal development. • **Quality and sources** (emphasize whole grains and fiber): - **Brown rice**, whole wheat bread, oats — whole grains provide fiber, B vitamins, and minerals - **Root vegetables and tubers** — sweet potato, taro, cassava - **Fruits** — local fruits (mango, papaya, guava, banana) provide carbohydrates, fiber, vitamins, minerals - **Legumes** — provide carbohydrates alongside protein and fiber • **Counsel on avoiding simple sugars and refined carbohydrates**: These cause rapid blood glucose spikes, particularly concerning in women at risk for gestational diabetes. Whole-grain versions are preferable to white rice or white bread when feasible. **Micronutrients**: Beyond iron and folic acid (covered earlier), pregnant women require adequate amounts of: • **Calcium** (discussed previously): 1000–1200 mg/day for bone development and pre-eclampsia prevention. Sources: small fish with bones (dilis, tinapa), tofu, dark leafy greens (malunggay, kangkong, pechay), milk. • **Iodine**: 220 mcg/day (slight increase from non-pregnant RDA of 150 mcg/day). Critical for fetal thyroid and brain development. Sources: iodized salt (ASIN Law), seafood, seaweed (if culturally acceptable). • **Vitamin C** (ascorbic acid): RDA increases to 85 mg/day in pregnancy (from 75 mg/day). Supports: - Collagen synthesis (important for connective tissue, blood vessel integrity, wound healing) - Iron absorption (particularly important when taking iron supplements) - Immune function - Sources: Citrus fruits (orange, calamansi, lemon), guava, tomatoes, papaya, mango, bell peppers. These are abundant and affordable in the Philippines. • **Vitamin B12**: 2.6 mcg/day (slight increase from non-pregnant requirement). Important for: - RBC formation and neurological development - DNA synthesis - Sources: Meat, fish, eggs, milk, dairy products. Vegetarian pregnant women may need supplementation if dietary intake is insufficient. • **Vitamin D**: While no official increase in RDA is mandated during pregnancy, adequate vitamin D (600–800 IU/day or 15–20 mcg/day) supports: - Calcium absorption (critical for fetal bone development) - Immune and hormonal function - Sources: Fatty fish (mackerel, salmon—less common in Philippines but sardines available), egg yolks, sun exposure. In the tropical Philippines, sun exposure is typically adequate for synthesis, though indoor workers and those in very polluted areas may benefit from dietary or supplemental sources. • **Other micronutrients**: - **Zinc**: Supports immune function and fetal development; sources include meat, fish, legumes, whole grains. - **Selenium**: An antioxidant that supports thyroid function; sources include seafood, meat, whole grains. **Pattern of Prenatal Nutrition Counseling**: The nurse provides nutrition counseling in a non-judgmental, supportive manner, recognizing that many pregnant women face barriers to optimal nutrition: 1. **Assess baseline dietary intake**: At the first visit, ask open-ended questions: "Tell me what you ate yesterday from morning to night. Where do you get your food? What are your favorite foods? Are there foods you can't afford? Are there cultural or religious foods you prefer or avoid?" 2. **Identify gaps**: Compare intake to recommendations. Common gaps in low-income Filipino populations include: - Inadequate protein (relying heavily on rice; meat, fish, or legumes eaten infrequently) - Low calcium (limited dairy or small-fish consumption) - Limited micronutrient variety (diet monotonous, heavily reliant on staple grains) - Inconsistent food availability due to seasonal variation, economic constraints, or geographic location (rural areas, island communities) 3. **Provide culturally tailored guidance**: Rather than prescribing unfamiliar foods, build on existing preferences and locally available, affordable options. For example: - If a woman's diet is rice-heavy, suggest combining rice with affordable proteins like mongo, dried fish, or eggs rather than requesting a complete dietary shift. - Malunggay (moringa) leaves are nutrient-dense, affordable, and familiar; emphasize their iron, calcium, and vitamin content and support for lactation. - Encourage seasonal fruits (local mango, papaya, guava) for vitamins and minerals; these are cheaper and fresher than imported options. 4. **Problem-solve barriers**: If food insecurity or poverty is the barrier: - Refer to food assistance programs (e.g., DOH nutrition programs, barangay relief, NGO food assistance). - Emphasize affordable protein sources (eggs, legumes, small dried fish). - Encourage gardening or community gardens if land is available. - Discuss meal planning and budgeting strategies. 5. **Reinforce supplement adherence**: Link supplements (iron-folic acid, calcium) to food sources and explain why they matter. Use visual aids or demonstrations if available. 6. **Monitor and adjust**: Review dietary intake and weight gain at each visit. If gain is poor or woman appears undernourished, intensify counseling and consider referral to a nutritionist or social worker.

While encouraging adequate nutrition, the nurse must also counsel pregnant women on substances and foods that pose risks to the developing fetus. These conversations are sensitive and require a non-judgmental, educational approach. **Alcohol**: • **Clear evidence**: There is no established safe level of alcohol consumption in pregnancy. Alcohol crosses the placenta freely and reaches fetal concentrations equal to maternal concentrations. Ethanol is directly teratogenic and disrupts fetal development through multiple mechanisms (oxidative stress, direct toxicity, nutrient deficiency). • **Fetal alcohol spectrum disorder (FASD)**: Includes a range of physical, behavioral, and cognitive abnormalities. **Fetal alcohol syndrome (FAS)**, the most severe form, is characterized by: - **Craniofacial abnormalities**: Microcephaly, short palpebral fissures (small eye openings), thin upper lip, smooth philtrum (groove between nose and lip) - **CNS dysfunction**: Intellectual disability, attention-deficit hyperactivity disorder, poor coordination, learning difficulties - **Growth restriction**: Short stature, low birth weight - **Other organ involvement**: Cardiac defects, urogenital abnormalities, skeletal deformities - These manifestations are permanent and may not be fully apparent at birth; behavioral and learning problems emerge over time. • **Risk increases with volume and timing**: Binge drinking and heavy daily use pose the highest risk, but even moderate drinking increases risk of spontaneous abortion, growth restriction, and neurodevelopmental problems. First-trimester exposure is particularly critical for organogenesis. • **Counseling approach**: - State clearly: "There is no safe amount of alcohol in pregnancy." - If the woman has consumed alcohol unknowingly early in pregnancy (before realizing she was pregnant), reassure her that occasional exposure carries lower risk, but emphasize complete abstinence going forward. - If the woman reports continued or heavy alcohol use, assess for alcohol-use disorder, involve her partner for support, and refer to addiction services or counseling if available. In the Philippines, this may involve community health workers, health centers, or NGOs supporting maternal health. - Use motivational interviewing rather than shame or judgment; emphasize love for the baby and maternal health as motivators. **Smoking and Secondhand Smoke**: • **Maternal smoking in pregnancy**: - Increases risk of spontaneous abortion, ectopic pregnancy, and placental abnormalities (placenta previa, abruption). - Causes **fetal growth restriction**: Nicotine causes vasoconstriction, reducing placental blood flow and oxygen delivery. Birth weight is typically 150–300 g lower in smoking pregnancies. - Increases risk of **prematurity** and **low birth weight** (a primary determinant of neonatal morbidity and mortality). - May increase risk of birth defects (cleft lip/palate, cardiac defects, urogenital abnormalities), though the evidence is less clear than for growth restriction and prematurity. - Impacts postnatal child health: secondhand smoke exposure increases risk of sudden infant death syndrome (SIDS), respiratory infections, and asthma in infants and children. - Reduces breastfeeding success (nicotine decreases milk supply; smoking is associated with earlier weaning). • **Secondhand smoke exposure**: - Carries similar risks to active smoking, though generally at lower magnitude. Pregnant women should avoid environments with heavy secondhand smoke exposure (households with smokers, workplaces, public spaces in settings where smoking is permitted). • **Counseling approach**: - Assess smoking status at the first visit and at each subsequent visit (many women underreport). - Provide evidence-based information on fetal risks in a non-judgmental manner. - Ask about motivation and barriers: "Do you want to quit? What would help you quit? What makes it hard to quit?" - Provide practical strategies: - Involve the partner or family in quitting; a partner's quit can double the pregnant woman's success rate. - Identify triggers (stress, after meals, with coffee) and alternative coping strategies (deep breathing, physical activity, snacking). - Consider nicotine replacement therapy (NRT) if available and woman is unwilling to quit cold turkey; while nicotine is not ideal, it is less harmful than smoking (which includes 7000 chemicals, 250 known toxins, 69 carcinogens). NRT dosing is lower and more controlled than smoking and lacks the combustion byproducts. NRT is generally considered safer than continued smoking in pregnancy, though many guidelines suggest cold-turkey quit if possible. - Pharmacological aids (varenicline, bupropion) are less studied in pregnancy; varenicline is Category C (use only if benefits clearly outweigh risks) and bupropion is Category B (more data supporting safety), so they may be considered in severe cases with specialist input. - Refer to smoking-cessation programs, health center counseling, or community support groups if available. - Reinforce at each visit; relapse is common and does not indicate failure—it is part of the quit process. Returning to cessation efforts is important. **Caffeine**: • **Guidelines**: WHO and most maternal health guidelines recommend **limiting caffeine to ≤200 mg/day** during pregnancy. This is roughly equivalent to: - 1–2 cups (200–300 mL) of brewed coffee (~95–100 mg caffeine per cup) - 2–3 cups of tea (~25–50 mg caffeine per cup) - 2–3 cans of cola (~35 mg caffeine per 12 oz) - 1–2 cups of hot chocolate (~5–10 mg caffeine per cup) • **Evidence**: High caffeine intake (>200 mg/day) has been associated with increased risk of spontaneous abortion and possibly fetal growth restriction in some studies, though the evidence is not definitive. The mechanism may involve caffeine's effects on placental blood flow and maternal metabolism. Concerns are greatest in the first and early second trimesters. • **Sources to assess and counsel on**: - Coffee (brewed or instant) - Tea (black tea, green tea to a lesser extent) - Chocolate and cocoa - Cola and energy drinks - Some over-the-counter medications (analgesics, cold medicines, allergy medications may contain caffeine) • **Counseling**: "Some caffeine is okay—up to about one or two cups of coffee a day. More than that may increase risk of miscarriage. If you drink a lot of coffee or tea, try to cut down gradually to avoid headaches. Decaffeinated versions are a good alternative." **Raw or Undercooked Meat, Fish, Eggs, and Dairy**: • **Risks**: - **Listeria monocytogenes**: A foodborne pathogen that can cause listeriosis, a severe infection in pregnancy with risk of fever, bacteremia, chorioamnionitis, abortion, preterm labor, or neonatal infection (meningitis, sepsis, chorioretinitis). Pregnant women are 10–20 times more susceptible to listeriosis than the general population. Sources include undercooked meat, smoked fish, unpasteurized dairy, deli meats (though less relevant in Philippines context), and soft cheeses made with unpasteurized milk. - **Toxoplasma gondii**: Transmitted through undercooked meat (especially pork and lamb) or contact with cat feces. Causes toxoplasmosis, which can result in congenital infection with serious sequelae (chorioretinitis, hydrocephalus, intracranial calcifications, microcephaly, fetal death). Risk of congenital transmission is highest when infection occurs in the first trimester but severity is greater when infection occurs later. - **Salmonella**: From undercooked poultry and eggs. Causes gastroenteritis, which while usually self-limited, can precipitate dehydration and preterm labor. - **Campylobacter and other enteropathogens**: From undercooked meat and poultry. • **Counsel on food safety**: - **Cook meat, poultry, fish, and eggs thoroughly**: All should reach safe internal temperatures (meat and poultry to 160–165°F / 71–74°C, fish to 145°F / 63°C, eggs until yolk is firm). - **Avoid deli meats and smoked fish** or reheat until steaming (though less relevant in typical Filipino diet, but relevant if woman has access to these foods). - **Use only pasteurized dairy products**: Unpasteurized milk and cheeses made from unpasteurized milk pose listeria risk. In the Philippines, most commercial milk is pasteurized, but small-scale or artisanal products may not be. - **Wash hands, utensils, and cutting boards** after handling raw meat to prevent cross-contamination with other foods. - **Cat exposure**: Pregnant women should avoid changing cat litter (risk of toxoplasma exposure). If litter must be changed, use gloves and hand hygiene. **High-Mercury Fish**: • **Risk**: Mercury accumulates in large predatory fish. High prenatal exposure to methylmercury causes neurological damage, impairing fetal brain development and resulting in cognitive deficits, developmental delay, cerebral palsy, and deafness. Minamata disease (severe mercury poisoning from occupational or contaminated food exposure) during pregnancy caused devastating congenital manifestations. • **Fish to limit or avoid** (generally high-mercury): - Shark, swordfish, king mackerel, tilefish (often advised to avoid completely in pregnancy) - Some tuna (especially large albacore tuna; canned light tuna is generally lower in mercury) • **Fish that are safe and encouraged** (low-mercury, rich in omega-3 and protein): - Salmon, anchovies, sardines, herring (small oily fish like these are commonly available in the Philippines and are nutrient-dense) - Tilapia, milkfish (bangus), and other locally abundant fish - Canned light tuna (in moderation) • **Counsel**: "Eat a variety of fish and seafood, but limit large predatory fish like shark and swordfish. Small fish like sardines, anchovies, and tilapia are great—they have omega-3s and less mercury. These are also affordable!" **Medications and Over-the-Counter Substances**: Pregnant women often take medications or herbal products without considering fetal safety. The nurse must emphasize: • **Consult before taking any medication, supplement, or herbal product**: Even over-the-counter drugs may pose risks (e.g., NSAIDs in third trimester can affect renal function and cause oligohydramnios; some herbal teas may stimulate contractions). • **Common concerns**: - **Analgesics**: Acetaminophen is generally considered safe throughout pregnancy. NSAIDs (ibuprofen, naproxen) are acceptable in first and second trimester but should be avoided in third trimester due to risks (oligohydramnios, premature ductus arteriosus closure, renal dysfunction, reduced amniotic fluid). - **Antimicrobials**: Penicillins and cephalosporins are safe; trimethoprim-sulfamethoxazole and quinolones have concerns; some others (tetracyclines, fluoroquinolones) should be avoided. - **Antihistamines and cold medicines**: Many are Category A or B and safe, but some contain pseudoephedrine or other decongestants with vasoconstrictive effects—verify before use. - **Herbal products**: Many are untested in pregnancy; pennyroyal, blue cohosh, and other herbal abortifacients should be strictly avoided. Even seemingly benign teas (ginger for nausea is generally safe; but some herbal teas may have uterine stimulant properties). • **Counsel**: "Always ask your doctor or nurse before taking any medicine, vitamin, or herbal product. Even over-the-counter things can affect the baby. Don't stop medicines your doctor prescribed, but check first if you want to add anything new." **Food Cravings and Pica**: • **Normal cravings**: Most pregnant women experience cravings for specific foods or flavors (chocolate, salty foods, fruits, sweets). These are generally benign and can be accommodated within a balanced diet. • **Pica**: The consumption of non-food substances (soil, starch, chalk, ice, clay) is concerning because: - It may indicate iron deficiency (and is a sign to check hemoglobin; iron treatment often resolves pica). - It may reflect cultural beliefs or availability of certain soil/clay preparations (in some cultures, certain earths or clays are traditionally consumed during pregnancy, believed to provide minerals or settle the stomach). Assessment should be non-judgmental; if the substance is contaminated, counsel on food safety; if hemoglobin is low, prioritize iron treatment. - Ingestion of contaminated soil, clay, or other non-food items carries risk of infections (parasites, toxoplasma), lead exposure (if clay or soil contains lead from polluted environments), and intestinal obstruction. • **Nursing approach**: Ask about pica non-judgmentally ("Do you have any unusual cravings or do you like to eat things like soil, starch, ice, or clay?"). If present: - Check hemoglobin; if low, prioritize iron supplementation and counseling. - Assess the specific item consumed. If it is a traditional or cultural preparation, understand its significance. - If the item may be contaminated, counsel on risks and suggest alternatives or safer sources if possible. - Provide referral to a registered dietitian if available for specialized counseling.

Certain maternal conditions or life circumstances require tailored nutritional assessment and counseling. **Nausea and Vomiting in Early Pregnancy (Hyperemesis Gravidarum)**: • **Prevalence and timing**: Nausea and vomiting affect 50–80% of pregnancies, typically starting at 4–6 weeks and resolving by 12–14 weeks (though some women experience it longer). The etiology is poorly understood but likely involves hormonal changes (rising hCG), altered gastric motility, and psychological factors. • **Impact on nutrition**: Mild-to-moderate nausea usually does not cause significant nutritional deficiency because intake is adequate once the first trimester resolves. However, severe hyperemesis gravidarum (persistent vomiting, weight loss >5%, electrolyte abnormalities, dehydration) is a medical condition requiring intervention. • **Nutritional counseling for nausea** (non-pharmacological first-line strategies): - **Small, frequent meals**: Instead of three large meals, eat 5–6 small meals or snacks throughout the day. This reduces gastric distention and may reduce nausea. - **Bland, easily digestible foods**: Crackers, toast, rice, broth, boiled vegetables, plain chicken, banana, applesauce, ginger, mint tea. - **Avoid triggers**: Strong odors, greasy or spicy foods, hot foods (try cold alternatives or cooler temperatures), caffeine, and iron supplements (temporarily, if severe; restart once tolerance improves). - **Dry crackers or toast before rising**: Eating a few crackers before getting out of bed, while still lying down, is a traditional remedy that many women find helpful. This may prevent or reduce nausea triggered by low blood sugar or standing. - **Ginger**: Ginger tea, ginger candies, or ginger supplements (1–1.5 g/day) have some evidence supporting efficacy for pregnancy-related nausea. - **Vitamin B6 (pyridoxine)**: 25–50 mg three times daily has evidence for reducing nausea severity. - **Acupressure**: Pressing the P6 (Neiguan) point on the inner forearm or wearing an acupressure wristband is a low-risk, non-pharmacological approach some women find helpful. - **Hydration**: Sip fluids throughout the day; oral rehydration solutions, coconut water, broth, or diluted fruit juice may be better tolerated than plain water. • **When to refer for medical evaluation**: Persistent vomiting preventing any oral intake, weight loss >5%, signs of dehydration (concentrated urine, thirst, dizziness), or abnormal electrolytes warrant evaluation for hyperemesis gravidarum and possible IV hydration or antiemetic medications. **Constipation**: • **Cause**: Progesterone relaxes smooth muscle, slowing gastrointestinal motility. Additionally, iron supplements exacerbate constipation by reducing gastric secretions and slowing transit. Dehydration and reduced activity in some pregnancies (especially bedrest situations) further increase risk. • **Counsel on management**: - **Increase dietary fiber**: Fruits (guava, papaya, mango, banana), vegetables (malunggay, kangkong, okra, squash), legumes (mongo beans, lentils), and whole grains provide fiber. Aim for 25–35 g/day. - **Increase fluid intake**: 8–10 glasses of water daily helps soften stools. In hot climates or with high activity, more fluids may be needed. - **Regular physical activity**: A 15–30 minute walk after meals can stimulate intestinal motility and improve regularity. - **Sitting position and time**: Encourage using the toilet in the morning (when reflex is strongest) and sitting unhurried; modern low-level toilets (squatting position) are more physiologically favorable for defecation than high Western-style toilets if accessible to the woman. - **Iron timing adjustment**: If constipation is severe, discuss with provider about taking iron every other day instead of daily (reduces dose-related constipation while still providing benefit), taking iron with food (reduces side effects, though slightly reduces absorption), or temporarily switching iron formulation (iron polysaccharide or fumarate may cause less constipation than ferrous sulfate). - **Medication if needed**: Stool softeners (docusate) are safe in pregnancy and can be used. Osmotic laxatives (polyethylene glycol, lactulose) are also safe. Stimulant laxatives (senna, bisacodyl) are generally safe in pregnancy but are second-line; castor oil should be avoided (may stimulate contractions). **Adolescent Pregnancy**: • **Nutritional challenges**: Adolescents have higher nutritional demands even when non-pregnant due to ongoing growth. When pregnant, they must meet demands for both their own continued growth and fetal development. This creates a significantly increased nutritional burden. • **Additional counseling priorities**: - Emphasize adequate caloric, protein, and micronutrient intake (especially calcium for ongoing skeletal development and iron for anemia prevention, which is particularly common in adolescents). - Assess for eating disorders or disordered eating (which may worsen in pregnancy due to body image concerns or continued restrictive practices). - Screen for food insecurity; adolescents often have limited control over food purchasing and may face household food shortage. - Provide parenting/lifestyle support: Adolescent mothers often balance school, work, and family obligations; nutritional counseling should acknowledge these stressors and offer practical, realistic guidance. - Involve parents/guardians in counseling when culturally appropriate and when the adolescent feels safe doing so. - Post-delivery, support exclusive breastfeeding and return to education if desired; breastfeeding increases caloric needs further (~500 kcal/day) in adolescents already nutritionally stretched. **Closely Spaced Pregnancies**: • **Definition and risks**: Pregnancies spaced <2 years apart (short inter-pregnancy interval) are associated with increased maternal and fetal adverse outcomes. The mother has not fully recovered from the prior pregnancy's nutritional demands or physiological changes (plasma volume expansion, blood loss, bone mineral density loss, iron stores depletion), placing the subsequent pregnancy at higher risk. • **Nutritional concerns**: - **Maternal anemia**: A prior pregnancy depletes iron stores; if inter-pregnancy interval is <2 years, maternal iron stores are incompletely replenished before the next pregnancy. This compounds the risk of anemia in the subsequent pregnancy. - **Micronutrient depletion**: Calcium, folate, and other micronutrient stores may not be fully restored. - **Maternal nutritional status**: Breastfeeding (if practiced) increases metabolic demands; if the mother is still lactating or recently weaned when the next pregnancy begins, her nutritional status may be compromised. • **Counseling and support**: - **Inter-pregnancy counseling** (at postpartum visits): Counsel women on contraceptive options and spacing to allow 18–24 months between births if feasible. This allows time for nutritional recovery, postpartum weight loss, and physiological recovery. - **Enhanced nutrition in closely-spaced pregnancies**: If a woman becomes pregnant with <2 years since the prior delivery, provide extra nutritional support, more frequent monitoring, and emphasis on supplement adherence. - **Postpartum nutrition**: Support exclusive breastfeeding (if woman chooses) while ensuring the mother's own nutrition is adequate; provide extra calories, protein, micronutrients for lactation. - **Community support**: Refer to social services, nutrition programs, and family planning for comprehensive support.

Prenatal care extends beyond physical health assessment; it encompasses comprehensive health teaching that empowers the woman and her family to recognize danger signs, make informed decisions, prepare for labor and delivery, and transition to parenthood. In the Philippine context, this aligns with the DOH's comprehensive maternal health program and the nurse's role in community health education per RA 9173. **Danger Signs in Pregnancy (Recognition and Reporting)**: One of the most critical and repeatedly reinforced messages in prenatal care is recognition of danger signs. Many maternal deaths are preventable if women report warning symptoms promptly; thus, teaching danger signs at every visit is essential. • **Danger signs that warrant urgent evaluation or referral to a facility** (review at every visit): - **Vaginal bleeding**: Any amount of blood from the vagina (not just spotting) in pregnancy may indicate placental abruption, placenta previa, miscarriage, infection, or other serious complications. Woman should report immediately to health center or hospital. - **Severe abdominal pain**: Sharp, localized, or sustained pain (not mild Braxton-Hicks contractions or round ligament stretching) may indicate abruption, appendicitis, ovarian torsion, or other emergencies. - **Leaking fluid from the vagina**: Watery fluid that continues to leak (not a one-time gush that stops) suggests rupture of membranes, which increases risk of infection and preterm labor. - **Severe, persistent headache**: Especially if accompanied by visual changes or upper abdominal pain, suggests pre-eclampsia. - **Vision changes**: Blurred vision, flashing lights, or temporary blindness may indicate pre-eclampsia-related complications. - **Upper abdominal (epigastric) pain**: Severe pain in the upper abdomen suggests possible eclampsia, hemolysis, elevated liver enzymes, low platelets (HELLP syndrome), or other serious hypertensive emergency. - **Severe facial or hand swelling (edema)**: Sudden swelling, especially in the face or hands (not just feet, which often swell normally in pregnancy), may indicate pre-eclampsia. - **Fever (temperature ≥38.5°C / 101.3°F)**: Fever in pregnancy suggests infection (UTI, pyelonephritis, pneumonia, chorioamnionitis). Prompt treatment is important to prevent progression. - **Burning or pain with urination**: Symptoms of UTI; important to treat because UTI progresses to pyelonephritis in pregnancy (which can precipitate preterm labor) and increases risk of premature rupture of membranes. - **Marked decrease in fetal movement**: A woman familiar with her baby's movements may notice sudden decrease (e.g., "My baby normally moves a lot, but today I've felt almost nothing in the past few hours"). This requires evaluation (NST, ultrasound) to assess fetal well-being. - **Preterm contractions**: Uterine contractions occurring before 37 weeks that are frequent (more than 4–5 in an hour), regular, and accompanied by other symptoms (bleeding, fluid leak, pain) suggest preterm labor. Even without other symptoms, if contractions are frequent and regular, evaluation is warranted. - **Convulsions**: Seizure activity in pregnancy is a medical emergency (eclampsia) requiring immediate hospitalization and delivery. - **Difficulty breathing**: Shortness of breath that is severe, sudden, or accompanied by chest pain may indicate pulmonary embolism, amniotic fluid embolism, pneumonia, or severe anemia. - **Loss of consciousness or fainting**: Syncope or near-syncope may indicate supine hypotensive syndrome (relieved by left-lateral positioning), severe anemia, or cardiac/neurological emergency. • **Teaching approach**: - Provide written materials (in local language) listing danger signs. - Use visual aids or demonstrations if available. - Ask the woman to repeat back the signs in her own words to confirm understanding. - Discuss her birth plan: "Where will you deliver? How will you get there? Who will accompany you? Do you know how to get in touch with us if you have concerns?" - Ensure she knows the health center phone number and visiting hours; encourage her to come in if unsure whether a symptom is serious ("It's better to come and be checked; it doesn't cost you anything and we want to make sure you and your baby are safe"). - Ask about barriers: "Is transportation a problem? Is there someone who can help you get to the hospital if you need to go?" Problem-solve (barangay can provide transport, neighbor may help, partner can take time off work). **Activity, Rest, and Exercise**: • **General guidance**: - **Moderate exercise is beneficial**: Walking, swimming, and low-impact activities are safe in uncomplicated pregnancies. Exercise improves maternal cardiovascular fitness, helps with weight management, reduces gestational diabetes risk, and improves mood. - **Frequency and intensity**: WHO recommends at least 150 minutes of moderate-intensity aerobic activity per week (this is the same as for non-pregnant adults); this can be broken into 30 minutes on 5 days weekly or other combinations. - **Avoid contact sports, jumping, or activities with fall risk**: High-impact activities or those with trauma risk (soccer, basketball, skiing) should be avoided due to risk of falls or direct abdominal injury. - **Avoid overheating**: Pregnant women have less ability to cool down; strenuous exercise in hot environments or in early pregnancy (when fetal temperature regulation is developing) should be avoided. Adequate hydration is crucial. • **Rest and positioning**: - **Left-lateral rest**: Sleeping or resting in the left-lateral (left side-lying) position improves placental perfusion because it relieves compression of the inferior vena cava (which occurs in supine position, causing up to 50% reduction in cardiac return). In the third trimester, when the enlarged uterus can compress major vessels, left-lateral rest is particularly important. Regular left-lateral rest improves fetal outcomes and maternal comfort. - **Supine hypotension**: In the third trimester, prolonged supine position can cause supine hypotensive syndrome (compression of IVC reducing cardiac return, causing sudden drop in BP, dizziness, nausea, syncope). This is rapidly relieved by rolling to the left side. - **Sleep and fatigue**: Fatigue is normal in the first and third trimesters due to physiological changes. Women should be reassured that daytime napping is normal and encouraged. Adequate sleep (7–9 hours/night) supports maternal and fetal health. - **Avoid prolonged standing**: Standing for long hours increases swelling and discomfort; women should be encouraged to sit periodically, elevate legs, and avoid tight socks or garters that impair circulation. • **Counsel**: "Exercise is good—walking every day is wonderful. Avoid sports where you might fall or get hit. Rest on your left side as much as you can, especially when sleeping or lying down. If you feel dizzy when lying on your back, roll to your left side and it should feel better. Rest when you're tired; it's normal to feel more tired in pregnancy." **Sexuality in Pregnancy**: • **General guidance**: Sexual activity is usually safe in normal, uncomplicated pregnancies throughout all three trimesters. Physical closeness and sexual expression support maternal well-being and partner bonding. • **When to avoid or modify sexual activity**: - **Vaginal bleeding**: If the woman has any vaginal bleeding, sexual activity should be avoided until the cause is determined and bleeding stops. - **Rupture of membranes**: If membranes have ruptured (leaking amniotic fluid), sexual activity should be avoided to prevent infection (ascending infection/chorioamnionitis). - **Preterm labor risk or symptoms**: If the woman is at risk for or has symptoms of preterm labor, sexual activity may need to be modified or avoided (discuss with provider). - **Placenta previa**: If placenta covers the cervix, penetrative intercourse should be avoided (though this is usually managed with modified activity or pelvic rest). - **Multiple gestation at high risk**: Twin or higher-order pregnancies complicated by growth discordance or other issues may require modified activity. - **Cervical insufficiency**: If the woman has a history of cervical incompetence or cerclage, sexual activity may need adjustment (discuss with provider). • **Counsel**: "Sexual activity is safe in pregnancy. You can continue to have sexual relations if you want to. Let us know if you have any concerns or if you're told to avoid it because of a complication. Your partner may need to be gentler or try different positions as your belly grows. Communication is important." **Substance and Medication Safety** (covered in detail in previous sections; key reinforcement here): • **At each visit, reiterate**: No alcohol, smoking should be quit, caffeine limited to ≤200 mg/day, all medications/supplements verified before use with the healthcare provider. • **Provide written materials** and discuss any concerns the woman raises. **Immunisation in Pregnancy**: • **Td**: Covered in detail earlier; reinforce schedule and provide card to track. • **Influenza (inactivated vaccine)**: Inactivated influenza vaccine is safe in all trimesters of pregnancy and is recommended. It protects the mother and passively protects the newborn (flu vaccination of pregnant women reduces influenza in infants under 6 months by ~50%). Live attenuated influenza vaccine (LAIV) is contraindicated in pregnancy. • **Live vaccines are contraindicated**: MMR, varicella, BCG, and other live vaccines should not be given in pregnancy. Women of childbearing age should be immunized before conception if needed. • **COVID-19 vaccines**: Inactivated COVID-19 vaccines are safe and recommended in pregnancy (especially in those at high risk for severe COVID-19). mRNA vaccines (Pfizer, Moderna) have substantial safety data supporting use in pregnancy. • **Counsel**: "Some vaccines are safe in pregnancy, like the flu shot and tetanus. Others are not. Always tell your healthcare provider you're pregnant before getting any vaccine. Live vaccines should wait until after you've delivered." **Preparation for Birth and Newborn Care**: • **Birth plan discussion** (aligns with DOH emphasis on facility-based delivery): - Encourage facility-based delivery (hospital or health center) as the safest option, particularly for primigravidas, older mothers, or those with risk factors. In the Philippines, skilled birth attendance is a key indicator of maternal safety. - Discuss place of birth (which facility), who will accompany her (partner, mother, friend), what support she wants during labor (presence of specific family members, certain comfort measures), and who will cut the cord if that is important to her. - Discuss pain management options (breathing techniques, position changes, massage, pharmacological options available at the facility). - Discuss whether she desires immediate skin-to-skin contact with baby, delayed cord clamping, and breastfeeding immediately after delivery (all supported by current evidence). - Document birth preferences in her health record so the delivery team is aware. • **Breastfeeding preparation**: - Assess breastfeeding intent and prior experience (multipara may have breastfed previous children). - Provide education on **exclusive breastfeeding for the first 6 months** (no formula, water, other foods—only breast milk) as recommended by WHO, UNICEF, and the DOH. This optimizes infant nutrition, growth, immune protection, and maternal-infant bonding. - Discuss benefits: improved infant immune function (reduced infection, diarrhea, respiratory illness), reduced SIDS risk, improved maternal-infant bonding, delayed return of menses (though not reliable as contraception), reduced breast cancer risk in mother, and economic savings. - Discuss common challenges (sore nipples, engorgement, perceived low supply) and solutions (proper latch, frequent feeding, support from lactation counselor or experienced family members). - Emphasize that help is available: health centers offer breastfeeding support; peer support groups may exist; encourage return visits to health center if breastfeeding is difficult. - If the woman is HIV-positive or has other contraindications to breastfeeding, provide counseling on safe formula feeding (preparing formula with clean water, avoiding mixed feeding). - Introduce partner or family to breastfeeding benefits so they support the mother. • **Newborn care teaching**: - **Cord care**: Demonstrate and practice cord care (keeping it dry and clean, watching for signs of infection—oozing, foul smell, redness). Traditional practices (application of various substances) should be assessed; if not harmful, can be incorporated, but emphasize cleanliness above all. - **Temperature regulation**: Newborns lose heat easily; discuss dressing warmly, keeping in skin-to-skin contact with mother, and warming techniques. - **Feeding cues**: Teach signs of hunger (rooting, hand to mouth, crying) vs. tiredness; avoid feeding for every cry. - **Sleep safety**: Discuss safe sleep practices (on back, firm surface, room-sharing without bed-sharing) to reduce SIDS risk. - **Newborn screening**: Inform about screening for birth defects (hearing, PKU, sickle cell, hypothyroidism if available at the facility), vitamin K and eye prophylaxis, and vaccinations (BCG, hepatitis B at birth). - **When to seek care**: Review signs that warrant immediate care (fever, difficulty feeding, persistent crying, vomiting, jaundice, lethargy, rash). - **Follow-up visits**: Schedule well-baby check-ups at 2 weeks, 6 weeks, and ongoing per national schedule. These assess infant feeding, growth, development, and maternal postpartum recovery. • **Partner/family involvement**: Encourage the woman to include her partner and/or mother/birth companion in prenatal classes or teaching sessions. Partner understanding of fetal development, labor support techniques, and newborn care improves birth outcomes and family adjustment. **Oral Health in Pregnancy**: • **Importance**: Oral health is often overlooked in prenatal care, but dental disease and poor oral hygiene are associated with increased preterm birth and low birth weight risk. Pregnancy-induced changes (increased estrogen causing gum inflammation, nausea reducing brushing, food cravings for sugary foods) increase dental disease risk. • **Counsel**: - Encourage regular dental visits (safe in pregnancy; second trimester is optimal timing if urgent care needed). Use of X-rays and local anesthesia is safe if necessary for acute problems. - Emphasize brushing twice daily with fluoridated toothpaste, flossing daily, and limiting sugary snacks and drinks. - Discuss pregnancy-related gingivitis (gum bleeding, swelling) and reassure that this usually resolves postpartum; reinforce hygiene to minimize symptoms. - If possible, address untreated cavities or periodontal disease during pregnancy to prevent worsening and associated systemic infection risk. **Seat Belt Use in Pregnancy**: • **Safe positioning**: Proper seat belt use in vehicles is important for maternal and fetal safety. Incorrect positioning (belt across the abdomen) can harm the fetus; proper positioning protects both. • **Correct technique**: - **Lap belt**: Should sit low, across the hip bones (below the pregnant belly), not across the uterus. - **Shoulder belt**: Should run between the breasts and over the shoulder, not across the neck or under the arm. - **Airbags**: Safe; should not be disabled. Airbags protect pregnant women in crashes just as in non-pregnant individuals. • **Counsel**: "Always wear your seatbelt when in a car, even during pregnancy. The lap belt should go below your belly, on your hips. The shoulder belt goes between your breasts. This keeps you and your baby safe if there's an accident." **Occupational and Environmental Exposures**: Briefly assess occupational and environmental exposures that may pose risks: • **Ask about work**: "What do you do for work? Are you exposed to chemicals, loud noise, heavy lifting, or extreme temperatures?" • **Counsel on modifications**: Heavy lifting and prolonged standing should be reduced; exposure to chemicals (pesticides, solvents, heavy metals) should be minimized; excessive noise should be avoided. • **Occupational hazards specific to Philippines context**: Agricultural workers may be exposed to pesticides; informal/street vendors may face heat, crowds, and poor sanitation; domestic workers may experience unsafe working conditions or abuse. • **Intimate partner violence (IPV) screening**: Pregnancy is a time of increased intimate partner violence risk. Universal screening should occur, ideally in private (alone with woman, away from partner/family). - **Ask**: "Do you feel safe at home? Has your partner ever hit, kicked, pushed, or hurt you? Has he ever forced you to have sexual relations? Do you feel afraid of him?" - **If IPV is disclosed**: Assess safety, provide information on resources (hotlines, shelters, legal support), and connect to social services. This is a mandatory reporting concern in many jurisdictions (check local law); in the Philippines, RA 9262 (Anti-Violence Against Women and Children Act) provides legal protections. - **Document carefully** (use facility protocols; may be required for legal proceedings). - **Support non-judgmentally**: Many women in IPV situations have complex reasons for staying; the nurse's role is to provide resources and support, not to judge or force decision-making.

Prenatal care is fundamentally a screening process. Routine assessment is designed to detect the conditions that most threaten mother and fetus, allowing early intervention. Key conditions screened for include: **Anaemia (Iron-Deficiency Anaemia)**: • **Prevalence**: Anaemia affects ~25–30% of pregnant women globally; rates are higher in low-income countries, including the Philippines, due to dietary iron inadequacy, infections (hookworm, malaria), and rapid population turnover (short inter-pregnancy intervals). • **Screening**: - **Baseline hemoglobin** is checked at the first antenatal visit (booking). - **Repeat hemoglobin** is checked in the third trimester (28–32 weeks) to detect gestational anaemia. - **Diagnostic threshold**: Hemoglobin <11.0 g/dL in the first and third trimesters is defined as anaemia in pregnancy (the threshold is lower than in non-pregnant women (~12 g/dL) because pregnancy normally causes a physiological decrease in Hgb due to hemodilution—the 40–50% increase in plasma volume exceeds the ~20% increase in RBC mass, resulting in relative anemia). - **Iron studies** (serum iron, ferritin, TIBC) may be checked if anaemia is present to determine if it is iron-deficient or due to other causes (though iron deficiency is the most common cause in pregnancy). • **Management of iron-deficiency anaemia**: - **Standard iron supplementation**: 60 mg elemental iron + 400 mcg folic acid daily is continued. If anaemia is present despite supplementation, assess adherence (side effects? missed doses?) and explore other causes (ongoing blood loss, infection, malabsorption). - **Counseling and adherence troubleshooting**: Reinforce the importance of iron for maternal health and fetal growth. If side effects prevent adherence, problem-solve (timing adjustments, taking with food, splitting dose, alternative formulation). - **Dietary assessment**: Ensure protein and vitamin C intake are adequate, as these support iron absorption and RBC formation. - **Transfusion**: Severe anaemia (Hgb <7–8 g/dL) or symptomatic anaemia (severe fatigue, dyspnea, cardiac symptoms) may require transfusion. This is relatively uncommon in routine prenatal care but may occur in resource-limited settings with delayed diagnosis or due to underlying severe malnutrition. - **Postpartum follow-up**: Anaemia often persists postpartum due to blood loss during delivery; iron supplementation should continue into the early postpartum period (at least 3 months postpartum, often longer). **Gestational Hypertension and Pre-eclampsia**: Hypertensive disorders of pregnancy affect ~10–15% of pregnancies and are a leading cause of maternal morbidity and mortality. Early detection through routine BP monitoring and symptom screening allows intervention that prevents eclampsia and other severe complications. • **Screening**: - **Blood pressure at every visit**: BP is measured at every antenatal visit and compared to baseline (ideally measured at booking). A rise of ≥30 mmHg systolic or ≥15 mmHg diastolic above baseline suggests hypertension, even if the absolute BP is <140/90. Absolute BP ≥140/90 is hypertensive by standard criteria. - **Urinalysis for proteinuria**: Urine dipstick at every visit screens for proteinuria (protein ≥1+ on dipstick or ≥30 mg/dL in 24-hour collection). Proteinuria + hypertension = pre-eclampsia. - **Clinical assessment for edema**: Facial and hand edema (not just ankle swelling, which is normal in pregnancy) combined with hypertension suggests pre-eclampsia. - **Symptoms**: At each visit, inquire about severe headache, visual changes (flashing lights, blurred vision), epigastric pain, and facial swelling. • **Diagnosis**: - **Gestational hypertension**: BP ≥140/90 (confirmed on two occasions ≥4 hours apart) in a woman who was normotensive at booking, without proteinuria, occurring after 20 weeks. - **Pre-eclampsia**: Gestational hypertension + one or more of the following: - Proteinuria (≥1+ on dipstick, ≥30 mg/dL in 24-hour urine, or protein/creatinine ratio ≥30 mg/mmol) - Headache (severe, unresponsive to analgesics) - Visual disturbances - Epigastric pain (right upper quadrant pain) - Pulmonary edema (rare, indicates severe pre-eclampsia) - Laboratory abnormalities (elevated liver enzymes, low platelets, elevated creatinine) - **Severe pre-eclampsia**: Pre-eclampsia with one or more severe features (BP ≥160/110, proteinuria ≥3+ or >5 g/24 hours, low platelets, elevated liver enzymes, severe symptoms). - **Eclampsia**: Seizures in a woman with pre-eclampsia; a medical emergency requiring immediate delivery. • **Management**: - **Gestational hypertension**: Close monitoring (more frequent visits); encourage lifestyle modification (rest, salt limitation if not already salt-restricted); antihypertensive medication if BP remains ≥150/95 (target is to avoid stroke and other maternal complications while avoiding over-treatment that might compromise placental perfusion). First-line agents are safe in pregnancy (methyldopa, nifedipine, labetalol). - **Pre-eclampsia without severe features**: Close monitoring, more frequent visits, home BP monitoring if possible, education on danger signs, antihypertensive therapy, magnesium sulfate if indicated by severe features, plan for delivery at 37 weeks (after which benefits of delivery usually outweigh risks of continued pregnancy). - **Severe pre-eclampsia**: Referral to hospital, possible admission, antihypertensive therapy, magnesium sulfate for seizure prophylaxis (loading dose 4 g IV over 20 minutes, then 1 g/hour maintenance), and plan for early delivery (at ≥34 weeks for severe pre-eclampsia remote from term; at term if ≥37 weeks). - **Eclampsia (seizures)**: Medical emergency; magnesium sulfate, airway protection, antihypertensive therapy, and immediate delivery once woman is stable. • **Prevention** (for women at risk): - **Calcium supplementation**: 1000–1200 mg/day reduces pre-eclampsia risk by ~30–35% in women with low dietary calcium intake. - **Aspirin**: Low-dose aspirin (81 mg/day) started after 12 weeks and continued until delivery reduces pre-eclampsia risk by ~10–15% in high-risk women (prior pre-eclampsia, multiple gestation, chronic hypertension, diabetes, renal disease). Available evidence supports its use in the Philippines context where pre-eclampsia burden is high. **Gestational Diabetes Mellitus (GDM)**: Gestational diabetes affects ~5–10% of pregnancies and is associated with maternal and fetal complications. Screening is standard in most developed healthcare systems and increasingly practiced in resource-limited settings. • **Screening**: - **Oral glucose tolerance test (OGTT)** at 24–28 weeks: After an 8–14 hour fast, woman drinks 75 g glucose (or sometimes a 50 g screening test is done first, with full OGTT if positive). Blood glucose is measured at fasting, 1 hour, 2 hours, and sometimes 3 hours. - **Diagnostic thresholds** (using WHO 2013 criteria, increasingly adopted globally): - Fasting glucose ≥126 mg/dL (≥7.0 mmol/L) - 1-hour glucose ≥180 mg/dL (≥10.0 mmol/L) - 2-hour glucose ≥153 mg/dL (≥8.5 mmol/L) - One elevated value meets criteria for GDM; in some systems, two elevated values are required. - **High-risk screening**: In some settings, women with risk factors (obesity, prior GDM, family history, advanced maternal age, ethnicity) undergo early screening (16–20 weeks); if negative, they are rescreened at 24–28 weeks. • **Management of GDM**: - **Dietary counseling** (first-line): A registered dietitian or trained nurse provides counseling on carbohydrate control (emphasizing complex carbohydrates and whole grains, avoiding simple sugars), meal spacing, portion control, and physical activity. Many women achieve glycemic control with diet alone. - **Self-monitoring of blood glucose**: Women measure fasting and postprandial (1–2 hours after meals) glucose using a home glucose monitor. Target values (typically fasting <95 mg/dL, postprandial <140 mg/dL at 2 hours) guide therapy. - **Insulin therapy**: If dietary management does not achieve targets or if glucose values are high, insulin is initiated. Insulin does not cross the placenta and is safe in pregnancy. Oral hypoglycemic agents (metformin, glibenclamide) are increasingly used and have evidence supporting safety in pregnancy, though insulin is traditional first-line. Some providers use metformin as add-on therapy with diet. - **Monitoring**: Women are seen frequently (every 1–2 weeks) for review of glucose logs, assessment of dietary adherence, adjustment of insulin, and fetal monitoring (NST if indicated for high-risk factors). - **Delivery and neonatal follow-up**: Women with GDM deliver near term (36–40 weeks); planned delivery at 40 weeks is typical if glucose is well-controlled and no other complications. At delivery, neonatal hypoglycemia risk is high if maternal glucose was elevated; neonates are monitored for blood glucose and fed early and frequently. Maternal glucose returns to normal postpartum, but women with GDM have 25–50% risk of type 2 diabetes in later life; postpartum screening and lifestyle counseling are important. **Infections** (Asymptomatic Bacteriuria, Urinary Tract Infection, and Sexually Transmitted Infections): • **Asymptomatic bacteriuria (ABU)**: - **Screening**: Urine culture or dipstick at first visit (some guidelines recommend dipstick; if positive, confirm with culture). ABU affects ~2–10% of pregnancies and is significant because it progresses to pyelonephritis in ~20–30% of untreated pregnant women (compared to ~0–1% of non-pregnant women). - **Pyelonephritis risks**: Sepsis, acute respiratory distress, preterm labor, fetal loss, low birth weight. - **Management**: Oral antibiotics (amoxicillin, cephalexin, nitrofurantoin until 36 weeks—avoid nitrofurantoin near term due to neonatal hemolysis risk) for 3–7 days. After treatment, repeat culture to confirm eradication; if positive despite treatment, investigate for anatomical abnormality (ultrasound) and consider prophylactic antibiotics for remainder of pregnancy. • **Symptomatic UTI** (dysuria, frequency, urgency): - **Management**: Same antibiotics as for ABU; ensure adequate hydration and symptom relief. • **Sexually transmitted infections (STIs)**: - **Screening**: At the first visit, syphilis (VDRL/RPR), HIV, and Hepatitis B (HBsAg) are screened. - **Syphilis**: - If positive on VDRL/RPR, confirm with treponemal test (FTA-ABS, TP-PA). - Untreated syphilis causes congenital syphilis (stillbirth, neonatal death, prematurity, low birth weight, hepatosplenomegaly, rash, bone abnormalities, neurosyphilis). Rates of congenital syphilis vary but can be devastating in high-prevalence areas. - **Treatment**: Penicillin G (benzathine penicillin G 2.4 million units IM weekly x 3 doses for early syphilis; or single dose plus additional doses for latent or tertiary syphilis). Penicillin is the only reliably effective treatment in pregnancy. Desensitization is available if penicillin allergy (though true allergy is rare); cephalosporins are an alternative with ~1–2% cross-reactivity in IgE-mediated allergy. - **Partner treatment**: Sexual partners must be treated to prevent reinfection. - **HIV**: - If positive, confirm with second test; assess CD4 count and viral load. - **Antiretroviral therapy (ART)**: All HIV-positive pregnant women should receive ART (preferred regimen typically includes zidovudine, lamivudine, and a third agent such as efavirenz or integrase inhibitor, depending on maternal CD4 and other factors). ART reduces vertical transmission risk from 15–45% to <1–2%. - **Mode of delivery**: Women with undetectable viral load (≤50 copies/mL on ART) can deliver vaginally; those with higher viral loads are typically advised cesarean delivery to reduce transmission risk. - **Infant prophylaxis**: Newborns of HIV-positive mothers receive antiretroviral prophylaxis for 4–6 weeks; feeding is formula-fed (exclusive, given the vertical transmission risk of breastfeeding) in settings where formula is affordable and safe. - **Partner notification and testing**: Essential for prevention and family planning. - **Hepatitis B**: - If HBsAg positive, assess HBeAg and viral load; if positive, risk of perinatal transmission is high (~70–90%). - **Infant prophylaxis**: Newborns born to HBsAg-positive mothers receive Hepatitis B immune globulin (HBIG) and Hepatitis B vaccine at birth (as part of the routine newborn vaccination); this prevents perinatal transmission in ~95% of cases. - **Maternal treatment**: Lamivudine or tenofovir may be used in pregnancy if indicated (high HBeAg positivity or high viral load), though many providers defer treatment until postpartum unless severe liver disease is present. Check local guidelines. - **Breastfeeding**: Safe if infant has received HBIG and vaccine (which are standard in most countries). - **Chlamydia and gonorrhea**: - Not universally screened in all settings, but important in high-prevalence populations. Untreated chlamydia and gonorrhea in pregnancy cause neonatal conjunctivitis (preventable with eye prophylaxis) and can cause pelvic inflammatory disease in pregnancy. - **Treatment**: Azithromycin for chlamydia (safe in pregnancy); ceftriaxone for gonorrhea. Partner treatment is essential. - **Genital herpes**: - Not routinely screened unless symptomatic. - **Primary herpes in third trimester** poses high risk of neonatal herpes (disseminated disease, CNS disease, death); vaginal delivery should be avoided (cesarean section recommended). - **Recurrent herpes** poses lower risk; vaginal delivery is safe if woman is asymptomatic at labor onset. - **Suppressive therapy**: Acyclovir or valacyclovir started at 36 weeks if history of genital herpes reduces risk of recurrence at delivery and neonatal herpes. **Rh Incompatibility**: • **Risk**: Rh-negative women carrying Rh-positive fetuses risk **Rh alloimmunization** (development of anti-D antibodies) if fetal blood mixes with maternal circulation (which can occur even in uncomplicated pregnancy due to fetomaternal hemorrhage, particularly after delivery, or may occur with abruption, placental trauma, or invasive procedures). • **Hemolytic disease of the newborn (HDN)**: If Rh alloimmunization occurs, IgG anti-D antibodies cross the placenta in subsequent Rh-positive pregnancies, causing hemolysis of fetal RBCs, resulting in anemia, hyperbilirubinemia, hydrops fetalis, and potentially fetal death or neonatal complications (severe jaundice, kernicterus, anemia). • **Prevention with anti-D immunoglobulin**: - **Antenatal anti-D**: 500 IU (100 mcg) IM at approximately 28 weeks of gestation to Rh-negative, non-sensitized women. - **Postpartum anti-D**: Within 72 hours of delivery of an Rh-positive infant (confirmed by infant blood type), 500 IU IM (or higher dose if large fetomaternal hemorrhage is suspected based on Kleihauer-Betke test or flow cytometry). - **Additional situations**: Anti-D is also given after pregnancy loss, invasive procedures (amniocentesis, CVS), or trauma (abruption, motor vehicle accident) in Rh-negative women. • **Counseling**: "Your blood type is Rh-negative, which means your baby might be Rh-positive. To prevent problems in future pregnancies, you'll receive an injection at 28 weeks and again after delivery. This is very important." **Abnormal Fetal Growth or Position**: • **Screening by fundal height**: - Fundal height measurement (in cm, from symphysis pubis to fundus) should track gestational age after 20 weeks (±2 cm margin of error). - **Deviation from expected**: If fundal height is 3+ cm below expected (e.g., 20 cm at 24 weeks), consider intrauterine growth restriction (IUGR), oligohydramnios, or incorrect dating. If 3+ cm above expected, consider polyhydramnios, macrosomia, or multiple gestation. • **Ultrasound**: Deviations from expected fundal height prompt ultrasound to assess: - Fetal biometry (estimated fetal weight, comparison to growth curve) - Amniotic fluid volume - Placental location and appearance - Fetal structure and position - Umbilical artery Doppler (if IUGR suspected) • **Fetal position and engagement**: - **Leopold's maneuvers** assess lie (longitudinal, transverse, oblique), presentation (cephalic/vertex, breech, shoulder), position (right/left, anterior/posterior), and degree of engagement (in fifths, with 5/5 being fully engaged = at the pelvic inlet, to 0/5 = completely in the pelvis). - **Abnormal lie or presentation**: Transverse lie and breech presentation have implications for mode of delivery (planned cesarean section for transverse lie at term; vaginal or cesarean delivery for breech, depending on maternal factors and fetal size). Women are counseled early in third trimester about external cephalic version (ECV) if indicated—a procedure to turn the fetus from breech to cephalic presentation, successful in ~50–60% of cases. **Rh Incompatibility and Fetal Monitoring in High-Risk Pregnancies**: • **Indications for antenatal fetal monitoring** (non-stress testing, biophysical profile, or continuous fetal monitoring): - Maternal diabetes (especially with poor glycemic control) - Maternal hypertension or pre-eclampsia - Intrauterine growth restriction - Decreased fetal movement - Rh disease (sensitized Rh-negative mother) - Postterm pregnancy (>42 weeks) - Maternal cardiac, renal, or systemic disease - Prior fetal loss or demise • **Methods** (NST, CST, BPP) are performed in the third trimester or when indicated; interpretation guides management (continued expectant management, admission, or delivery). These screening processes, integrated into every prenatal visit, form the backbone of prenatal care and allow early detection and management of the most common and serious complications of pregnancy.